KR20040005407A - Anti-aging composition - Google Patents
Anti-aging composition Download PDFInfo
- Publication number
- KR20040005407A KR20040005407A KR1020020039954A KR20020039954A KR20040005407A KR 20040005407 A KR20040005407 A KR 20040005407A KR 1020020039954 A KR1020020039954 A KR 1020020039954A KR 20020039954 A KR20020039954 A KR 20020039954A KR 20040005407 A KR20040005407 A KR 20040005407A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- vitamin
- extract
- weight
- aging
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
Description
본 발명은 항산화제, 아미노산류, 생약류, 비타민 및 미네랄을 함유하는 조성물로서, 노화 방지 작용을 효과적으로 증가시킨 항노화 조성물에 관한 것이다.The present invention relates to an anti-aging composition comprising an antioxidant, amino acids, herbal medicines, vitamins and minerals, wherein the anti-aging action is effectively increased.
최근 밝혀진 노화의 원인은 활성 산소에 의한 세포 파괴 및 유전자 손상에 의하여 노화가 일어나는데, 이 노화 과정에서 가장 뚜렷하게 나타나는 인체내 변화 중의 하나가 호르몬 결핍 현상이다. 따라서, 노화 방지를 위해 항산화제의 급여에 의해 세포를 보호함과 동시에, 호르몬 결핍에 따른 여러 가지 증상을 치료 및/또는 예방함으로써, 효과적으로 노화를 억제할 수 있다. 노화와 관련있는 호르몬으로는 성장호르몬(HGH), DHEA호르몬, 테스토스테론, 에스트로겐, 멜라토닌, 갑상선호르몬등이며 이들 호르몬은 30세이후부터 정상치 이하로 줄어들면서 노화현상이 일어난다.노화증상은 대부분 무기력해지고 불안해지며 성기능이 감소되고 주름살이 생기고 체내의 지방질이 증가되며 각종노인성질환, 즉 심장질환, 고혈압, 당뇨병, 골다공증, 중풍, 치매, 백내장, 시력감퇴, 이명등이 발명한다. 예컨대, 여성은 폐경기 이후에 에스트로겐이 현저히 감소되고 여러 노화 현상이 나타나는데, 에스트로겐을 보충하면 피부 기능의 퇴화, 골다공증, 동맥경화증 등을 완화시킬 수 있으며, 성장호르몬은 근육을 늘리고 살같이 두꺼워지며, 골밀도가 높아지게하는 특징이 있다. 한편, 호흡이나 음식물, 공해, 스트레스, 약물대사, 전자파등으로 인하여 활성산소가 발생하여 몸의 세포, 유전자, 단백질등을 공격하거나 변형시켜 암이나 치매, 만성질환등이 발생되고 특히 암의 주요 요인이 활성산소이며 이것이 노화를 촉진시키는 요인으로도 작용한다. 따라서 항산화 작용은 세포 수준의 산화 과정에서 일어나는 여러 현상을 막아줌으로써, 세포를 보호함과 동시에 노화를 억제한다. 또한 비타민은 체내에 함유된 영양소로서 성장 촉진과 건강 유지에 필수적이며, 미네랄은 인체의 성장과 유지 및 생식에 비교적 소량이 필요한 영양소로서, 신체내 산-염기 평형 및 조직(연결 조직 등) 형성, 세포 내외의 물의 균형 조절에 도움을 주어 노화 억제에 도움을 준다.Recently, the cause of aging is aging caused by cell destruction and gene damage caused by free radicals. One of the most obvious changes in the body during the aging process is hormonal deficiency. Therefore, by protecting the cells by supplementing antioxidants to prevent aging, by treating and / or preventing various symptoms caused by hormone deficiency, aging can be effectively suppressed. Hormones related to aging include growth hormone (HGH), DHEA hormone, testosterone, estrogen, melatonin, and thyroid hormones. These hormones are reduced to below normal levels after age 30. Aging symptoms are mostly lethargic and unstable. Sexual function is reduced, wrinkles are formed, fat in the body is increased, and various elderly diseases, namely heart disease, hypertension, diabetes, osteoporosis, stroke, dementia, cataract, decreased vision, tinnitus, and the like. For example, in men, postmenopausal estrogens are markedly reduced and various aging phenomena occur.Replenishing estrogens can alleviate the deterioration of skin function, osteoporosis, arteriosclerosis, growth hormones increase muscle tone, thicken flesh, and bone density. There is a characteristic that makes it higher. On the other hand, free radicals are generated due to breathing, food, pollution, stress, drug metabolism, and electromagnetic waves, attacking or modifying cells, genes, and proteins in the body, resulting in cancer, dementia, and chronic diseases. This is free radicals, and it also acts as a factor in aging. Thus, antioxidant activity prevents many phenomena occurring at the cellular level, thereby protecting the cells and inhibiting aging. In addition, vitamins are nutrients contained in the body, which are essential for promoting growth and maintaining health, and minerals are nutrients that require relatively small amounts for growth, maintenance, and reproduction of the human body, forming acid-base equilibrium and tissues (connective tissue, etc.) in the body, It helps to control the balance of water inside and outside the cell, which helps to suppress aging.
본 발명은 호르몬 분비를 유도 및 촉진하고, 유리 라디칼에 의한 신체 기관 및 피부 등의 노화를 억제하는데 유용한, 항산화제, 아미노산류, 생약류, 비타민 및 미네랄 함유 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide an antioxidant, amino acids, herbal medicines, vitamins and mineral-containing compositions which are useful for inducing and promoting hormone secretion and for inhibiting aging of body organs and skin by free radicals.
본 발명은 ⅰ) 카텍틴(Catectin)류, 플라보노이드(Flavinoid)류, 카로티노이드(Carotenoid)류, 효모유래 글루타티온(glutathione), 포도씨 추출물, 피크제놀, 녹차 추출물, 대두 추출물, 현미 배아 추출물 함유 제제 및 이들의 배합물로 이루어진 군으로부터 선택되는 1-35 중량%의 항산화제; ⅱ) 글리신, L-글루타민, L-라이신, 아르기닌, 트립토판, 티로신, 카르니틴, 오르니틴, 단백가수분해물(peptide류) 및 이들의 배합물로 이루어진 군으로부터 선택되는 5-60 중량%의 아미노산류; ⅲ) d-토코페롤, 베타카로틴, 비타민 C, 비타민 A, 비타민 B군, 엽산, 비오틴, 이노시톨, 비타민 P 및 이들의 배합물로 이루어진 군으로부터 선택되는 0.01-10 중량%의 비타민류; 및 ⅳ) 칼슘, 인, 마그네슘, 나트륨, 칼륨, 철, 요오드, 아연, 구리, 셀레늄, 망간, 크롬, 몰리브덴 및 이들의 배합물로 이루어진 군으로부터 선택되는 0.5-16 중량%의 미네랄류; vi) 녹용, 인삼, 당귀, 황기, 숙지황, 영지, 오가피, 산약, 갈근, 복분자, 산수유, 구기자, 로얄제리, 화분, 레드클로바, 석류 추출물, 및 이들의 배합물로 이루어진 군으로부터 선택되는 5-40 중량%의 생약류을 함유하는 것을 특징으로 하는 항노화(anti-aging) 조성물을 제공한다.The present invention includes catechins (Catectin), flavonoids (Flavinoids), carotenoids (Carotenoids), yeast derived glutathione (glutathione), grape seed extract, picenol, green tea extract, soybean extract, brown rice germ extract-containing formulations and these 1-35% by weight antioxidant selected from the group consisting of; Ii) 5-60% by weight of amino acids selected from the group consisting of glycine, L-glutamine, L-lysine, arginine, tryptophan, tyrosine, carnitine, ornithine, peptides and combinations thereof; Iii) 0.01-10% by weight of vitamins selected from the group consisting of d-tocopherol, beta carotene, vitamin C, vitamin A, vitamin B group, folic acid, biotin, inositol, vitamin P and combinations thereof; And iii) 0.5-16% by weight minerals selected from the group consisting of calcium, phosphorus, magnesium, sodium, potassium, iron, iodine, zinc, copper, selenium, manganese, chromium, molybdenum and combinations thereof; vi) 5-40 selected from the group consisting of deer antler, ginseng, donkey, astragalus, succinate, ganoderma lucidum, ogapi, medicinal herb, brown root, bokbunja, cornus, wolfberry, royal jelly, pollen, red clova, pomegranate extract, and combinations thereof It provides an anti-aging composition, characterized in that it contains by weight of the herbal medicines.
카텍틴(Catectin)류, 플라보노이드(flavonoid)류, 카로티노이드 (Carotenoid)류, 효모 유래 글루타티온(glutathione), d-토코페롤, 베타카로틴, 비타민 C, 비타민 A 함유 제제 등과 같은 항산화제는 세포 수준의 산화 과정에서 일어나는 여러 현상, 예컨대 산화적 스트레스(oxidative stress)를 방지할 수 있다. 항산화제는 총체적인 항산화 작용을 방해하지 않고, 산화에 의한 손상을 방지하는 것이다. 항산화제는 노화의 원인이 되는 유리 라디칼이 체내에 형성되는 것을 저지할 수 있다.Antioxidants, such as catechins, flavonoids, carotenoids, yeast-derived glutathiones, d-tocopherols, beta carotene, vitamin C, and vitamin A-containing agents, are at the cellular level Many phenomena occur in the body, such as oxidative stress. Antioxidants do not interfere with the overall antioxidant action, and prevent oxidation damage. Antioxidants can prevent the formation of free radicals that cause aging in the body.
오르니틴, 글리신, L-글루타민, L-라이신, 아르기닌 및 트립토판, 티로신, 단백가수분해물등과 같은 아미노산류 및 녹용, 인삼, 황기, 숙지황, 당귀, 산약, 갈근, 오가피등과 같은 생약류는 호르몬 분비를 촉진시킴으로써 노화 현상을 억제할 수 있다. 예를들면, 오르니틴, 아르기닌, 라이신, 글루타민, 글리신 등은 체내에서 성장 호르몬 분비를 유도하는 기능이 있고 트립토판은 신경전달물질인 세로토닌 분비와 멜라토닌 생성을 촉진한다. 또한 단백가수분해물은 성장 호르몬 분비를 촉진하며 각종 호르몬 합성에 필요 물질로 사용된다. 또한 녹용은 뿔 생장 자극 물질이 있으며, 테스토스테론을 포함한 남성 호르몬 변화와 밀접한 관계가 있으며, 갈근은 에스트로겐이라는 여성호르몬의 전구체 물질을 함유하고 있다.Amino acids, such as ornithine, glycine, L-glutamine, L-lysine, arginine and tryptophan, tyrosine, protein hydrolysates, and herbal medicines such as deer antler, ginseng, Astragalus, spermatozoon, Angelica, medicinal herbs, roots, and scabies Aging can be suppressed by promoting secretion. For example, ornithine, arginine, lysine, glutamine, and glycine have a function of inducing growth hormone secretion in the body, and tryptophan stimulates the production of neurotransmitters serotonin and melatonin. Protein hydrolysates also promote growth hormone secretion and are used as a necessary substance in the synthesis of various hormones. Deer Antlers also have horn growth stimulants, which are closely related to testosterone changes, including testosterone, and the roots contain precursors of female hormones called estrogens.
비타민은 체내에 함유된 영양소로서 성장 촉진과 건강 유지에 필수적인데 특히, 비타민 B6은 호르몬 합성에 관여하며, 비타민 B2와 니아신 등은 피부 보호 및 성장 촉진에 도움을 주고, 비타민 C는 세포 간의 결합 조직을 강화시키고, 철과 칼슘의 흡수를 촉진시키며, 혈액 재생 및 모세관벽 강화의 기능이 있고, 치아, 뼈 등의 발육을 촉진시키며, 세균에 대한 저항력을 증가시킨다. 비타민 E는 항산화제로서 사용되는데, 노화 방지, 동맥 경화 및 성인병 예방, 동물의 생식 기능 증진 등에 도움을 준다.Vitamins are nutrients contained in the body and are essential for promoting growth and maintaining health. In particular, vitamin B6 is involved in hormonal synthesis, vitamin B2 and niacin help protect and promote skin growth, and vitamin C is a connective tissue between cells. It enhances the absorption of iron and calcium, has the function of blood regeneration and capillary wall strengthening, promotes the development of teeth, bones, etc., and increases the resistance to bacteria. Vitamin E is used as an antioxidant and helps prevent aging, harden the arteries and prevent adult diseases, and improve the reproductive function of animals.
미네랄은 인체의 성장과 유지 및 생식에 비교적 소량이 필요한 영양소로서, 신체내 산-염기 평형 및 조직(연결 조직 등) 형성, 세포 내외의 물의 균형 조절에 도움을 준다. 예컨대, 아연은 각종 대사조절 및 호르몬 작용에 도움을 주며, 요오드는 갑상선 호르몬 조절 작용에 관여한다. 또한, 혈액 중에 칼슘이 부족하면 부갑상선 호르몬인 파라토르몬(PHT)이 작용하여 뼈에 축척되어 있는 칼슘을 녹여 뼈의 약화를 초래해 노화를 촉진시킨다.Minerals are nutrients that require relatively small amounts for growth, maintenance and reproduction of the human body. They help to balance acid-base equilibrium and formation of tissues (connective tissue, etc.) and balance water in and out of cells. For example, zinc assists in various metabolic and hormonal actions, while iodine is involved in thyroid hormone control. In addition, the lack of calcium in the blood parathyroid hormone (PHT) acts to dissolve the calcium accumulated in the bones to cause bone weakening and promote aging.
본 발명의 항노화 조성물은 방향제, 감미제, 식용 색소, 안정화제 기타 보존제를 추가로 포함할 수 있다. 예컨대, 상기 항노화 조성물은 0.01-0.2 중량%의 소르비톨, 0.01-0.05 중량%의 안식향산, 0.01-0.05 중량%의 천연 오렌지향, 0.01-0.05 중량%의 과당 및 0.01-0.05 중량%의 구연산을 추가로 포함할 수 있다. 또한, 본 발명의 항노화 조성물은 정제, 산제, 과립제, 캡슐제, 환제, 내용액제 등의 형태일 수 있다.The anti-aging composition of the present invention may further comprise fragrances, sweeteners, food colorings, stabilizers and other preservatives. For example, the anti-aging composition adds 0.01-0.2 wt% sorbitol, 0.01-0.05 wt% benzoic acid, 0.01-0.05 wt% natural orange flavor, 0.01-0.05 wt% fructose and 0.01-0.05 wt% citric acid It can be included as. In addition, the anti-aging composition of the present invention may be in the form of tablets, powders, granules, capsules, pills, contents solution.
실시예Example
하기 실시예는 본 발명의 예시에 불과한 것으로서, 이에 의해 본 발명의 범주가 제한되는 것으로 해석되어서는 아니된다. 본 발명의 기술적 사상의 범주 내에서 다양한 변형 및 수정이 가능하다는 것을 당업자는 이해할 수 있을 것이다.The following examples are merely illustrative of the present invention and should not be construed as limiting the scope of the present invention. Those skilled in the art will understand that various modifications and variations are possible within the scope of the technical idea of the present invention.
실시예 1: 항노화 조성물의 제조Example 1: Preparation of Anti-Aging Composition
18 내지 25 의 온도 및 0.1 기압 내지 10 기압의 압력에서 5 중량%의 글루타치온효모, 5 중량%의 녹차추출물, 4 중량%의 셀레늄효모, 3 중량%의 포도씨 추출물, 3 중량%의 피크제놀, 3 중량%의 화분, 3 중량%의 레드클로바, 3 중량%의 클로렐라, 15 중량%의 아르기닌, 6 중량%의 L-글루타민, 6 중량%의 L-라이신, 5 중량%의 글리신, 5 중량%의 카르니틴, 3 중량%의 티로신, 2 중량%의 트립토판, 5 중량%의 비타민C, 1 중량%의 베타카로틴, 1 중량%의 d-토코페롤, 1.5 중량%의 비타민 B3, 0.5 중량%의 비타민 B6, 0.5 중량%의 비타민 B1, 0.1 중량%의 엽산, 5 중량%의 칼슘, 5 중량%의 마그네슘, 5 중량%의 칼륨, 1 중량%의 철, 1 중량%의 구리, 0.01 중량%의 요오드, 1.7 중량%의 아연 및 0.3 중량%의 망간을 30시간 동안 고루게 혼합하였다. 이어서, 혼합물을 캡슐에 충진하였다.5 wt% glutathione yeast, 5 wt% green tea extract, 4 wt% selenium yeast, 3 wt% grape seed extract, 3 wt% pycnenol, 3 at a temperature of 18-25 and a pressure of 0.1-10 wt Wt% pollen, 3 wt% red clova, 3 wt% chlorella, 15 wt% arginine, 6 wt% L-glutamine, 6 wt% L-lysine, 5 wt% glycine, 5 wt% Carnitine, 3 wt% tyrosine, 2 wt% tryptophan, 5 wt% vitamin C, 1 wt% beta carotene, 1 wt% d-tocopherol, 1.5 wt% vitamin B3, 0.5 wt% vitamin B6, 0.5 wt% vitamin B1, 0.1 wt% folic acid, 5 wt% calcium, 5 wt% magnesium, 5 wt% potassium, 1 wt% iron, 1 wt% copper, 0.01 wt% iodine, 1.7 Weight percent zinc and 0.3 weight percent manganese were mixed evenly for 30 hours. The mixture is then filled into capsules.
실시예 2: 항노화 조성물의 제조Example 2: Preparation of Anti-Aging Composition
18 내지 25 의 온도 및 0.1 기압 내지 10 기압의 압력에서 5 중량%의 녹용, 5 중량%의 산약, 5 중량%의 갈근, 5 중량%의 오가피, 4 중량%의 인삼, 4 중량%의 당귀, 15 중량%의 아르기닌, 6 중량%의 L-글루타민, 6 중량%의 L-라이신, 5 중량%의 글리신, 5 중량%의 카르니틴, 3 중량%의 티로신, 2 중량%의 트립토판, 5 중량%의 비타민C, 1 중량%의 베타카로틴, 1 중량%의 d-토코페롤, 1.5 중량%의 비타민 B3, 0.5 중량%의 비타민 B6, 0.5 중량%의 비타민 B1, 0.1 중량%의 엽산, 5 중량%의 칼슘, 5 중량%의 마그네슘, 5 중량%의 칼륨, 1 중량%의 철, 1 중량%의 구리0.01 중량%의 요오드, 1.7 중량%의 아연 및 0.3 중량%의 망간을 30시간 동안 고루게 혼합하였다. 이어서, 반응 혼합물을 캡슐에 충진하였다.5% by weight antler, 5% by weight powder, 5% by weight of brown root, 5% by weight of ginseng, 4% by weight of ginseng, 4% by weight of Angelica, at a temperature of 18 to 25 and a pressure of 0.1 to 10 atmospheres, 15 weight percent arginine, 6 weight percent L-glutamine, 6 weight percent L-lysine, 5 weight percent glycine, 5 weight percent carnitine, 3 weight percent tyrosine, 2 weight percent tryptophan, 5 weight percent Vitamin C, 1 wt% beta carotene, 1 wt% d-tocopherol, 1.5 wt% vitamin B3, 0.5 wt% vitamin B6, 0.5 wt% vitamin B1, 0.1 wt% folic acid, 5 wt% calcium , 5 wt% magnesium, 5 wt% potassium, 1 wt% iron, 1 wt% copper 0.01 wt% iodine, 1.7 wt% zinc and 0.3 wt% manganese were mixed evenly for 30 hours. The reaction mixture was then filled into capsules.
실시예 3: 항노화 조성물 복용 후의 성장호르몬 분비촉진효과Example 3 Growth Hormone Secretion Effect after Anti-Aging Composition
상기 실시예 1 및 2에 의해 제조된 항노화 조성물을 10명의 성인 남녀(35세-65세)에게 8주간 경구 복용후 혈액을 채취하여 혈중 성장호르몬(IGF-1)값을 측정한 결과를 표 1로 나타냈다.Blood anti-aging compositions prepared according to Examples 1 and 2 were taken after oral administration to 10 adult men and women (35 to 65 years) for 8 weeks to measure blood growth hormone (IGF-1) values. 1 is shown.
실시예 4: 항노화 조성물의 항산화 효과Example 4: Antioxidant Effect of Anti-Aging Compositions
상기 실시예 1 및 2에 의해 제조된 항노화 조성물을 사료에 5%혼합하여 마우스에 2주간 자유섭취 시켰고 비타민 C도 투여하여 비교했으며, 2주간후 뇌,심장의 장기를 적출하여 각 장기중의 과산화지질, SOD의 측정을 행했다.5% of the anti-aging composition prepared in Examples 1 and 2 was mixed with feed and freely ingested in mice for 2 weeks and compared with administration of vitamin C. After 2 weeks, the organs of the brain and heart were extracted and peroxidated in each organ. Lipids and SOD were measured.
본 발명의 노화 방지 조성물은 성장 호르몬등 각종호르몬 분비를 유도 및 촉진하여 노화증상을 개선하고, 유리 라디칼에 의한 신체 기관 및 피부등의 노화를 억제함으로써 항노화 작용을 효과적으로 증진 시킨다. 특히, 본 발명의 노화방지 조성물은 항산화제, 아미노산류, 생약류, 비타민 및 미네랄을 함유함으로써 성인병과 노인성 질환을 예방/개선하고 성장기 청소년의 두뇌기능 개선과 왜소증을 예방/치료 할 수도 있다.The anti-aging composition of the present invention induces and promotes the release of various hormones such as growth hormones to improve the aging symptoms, and effectively enhance the anti-aging action by inhibiting the aging of body organs and skin by free radicals. In particular, the anti-aging composition of the present invention may contain antioxidants, amino acids, herbal medicines, vitamins and minerals to prevent / improve adult diseases and senile diseases, and to prevent / treat brain function improvement and dwarfism in growing adolescents.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020039954A KR20040005407A (en) | 2002-07-10 | 2002-07-10 | Anti-aging composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020039954A KR20040005407A (en) | 2002-07-10 | 2002-07-10 | Anti-aging composition |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20040005407A true KR20040005407A (en) | 2004-01-16 |
Family
ID=37315733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020039954A KR20040005407A (en) | 2002-07-10 | 2002-07-10 | Anti-aging composition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20040005407A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100528720B1 (en) * | 2002-08-29 | 2005-11-15 | 주식회사 메디넥스 | Nutritional composition of health food inhibiting heavy metal accumulation |
KR100706175B1 (en) * | 2003-11-14 | 2007-04-11 | 제주특별자치도 | New bacterium Flavococcus chejuensis producing zeaxanthin and production method of zeaxanthin using thereof |
KR101315325B1 (en) * | 2006-06-30 | 2013-10-07 | (주)아모레퍼시픽 | A composition for skin external application containing antioxidant components for improving skin wrinkle and skin whitening |
KR20200133047A (en) * | 2019-05-15 | 2020-11-26 | 순천대학교 산학협력단 | Antioxidant and whitening composition |
CN116327652A (en) * | 2023-02-17 | 2023-06-27 | 杭州睿研前瞻生物科技有限公司 | Skin anti-aging composition and preparation method thereof |
-
2002
- 2002-07-10 KR KR1020020039954A patent/KR20040005407A/en not_active Application Discontinuation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100528720B1 (en) * | 2002-08-29 | 2005-11-15 | 주식회사 메디넥스 | Nutritional composition of health food inhibiting heavy metal accumulation |
KR100706175B1 (en) * | 2003-11-14 | 2007-04-11 | 제주특별자치도 | New bacterium Flavococcus chejuensis producing zeaxanthin and production method of zeaxanthin using thereof |
KR101315325B1 (en) * | 2006-06-30 | 2013-10-07 | (주)아모레퍼시픽 | A composition for skin external application containing antioxidant components for improving skin wrinkle and skin whitening |
KR20200133047A (en) * | 2019-05-15 | 2020-11-26 | 순천대학교 산학협력단 | Antioxidant and whitening composition |
CN116327652A (en) * | 2023-02-17 | 2023-06-27 | 杭州睿研前瞻生物科技有限公司 | Skin anti-aging composition and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6896910B2 (en) | Anti-fatigue and tonic agent containing wild ginseng | |
JP3512198B2 (en) | Two-phase preparation | |
US20190374459A1 (en) | Edible cricket composition for preventing hair loss, improving hair follicle, and promoting hair regrowth | |
CN112739222A (en) | Anti-aging agent and anti-aging method | |
JP2018521118A (en) | A composition for preventing and treating muscular diseases or improving muscle function, comprising morsin, kwanonji or mulberry white skin | |
JP2010001282A (en) | Isothiocyanate-containing composition, food, foodstuff, medicine, cosmetic, daily necessary and miscellaneous good | |
US8062679B2 (en) | Composition for maintaining androgen and androgen-like uptake potential by cells | |
KR20040005407A (en) | Anti-aging composition | |
KR101809379B1 (en) | Composition comprising Diosmin or as active ingredients for Preventing or treating muscle disease | |
KR102163445B1 (en) | Composition comprising chp (cyclo-his pro) for preventing, improving or treating of bone loss related disease | |
US20070212407A1 (en) | Oral Composition A First Composition (A) And A Second Composition (B) As A Combination Product For Separate Or Consecutive Administration In The Cosmetic Treatment Of The Human Body | |
JP2007236308A (en) | Food composition | |
EP1520584A1 (en) | Composition for the activation of the immune system | |
JP5119393B2 (en) | Antioxidants, anti-inflammatory agents and whitening agents and their use | |
KR100419121B1 (en) | A functional food Containing herbes composition for female menopausal disorder | |
US6024984A (en) | Composition containing an extract from muirapuama root and plant worm extract | |
CN105942492A (en) | Pufanxi capsules (capsules prepared from procyanidine, lycopene, and selenium carrageenan) capable of enhancing anti-oxidation ability of cell membranes and preparation method thereof | |
KR102567263B1 (en) | Composition for preventing, treating or improving metabolic diseases containing essential oil mixture of Mentha haplocalyx, Citrus unshiu peel and Coicis Semen | |
EP3449736B1 (en) | Composition for relieving menopausal symptom or osteoporosis | |
KR100580070B1 (en) | Food for whitening of skin | |
ES2663392B2 (en) | Nutritional supplement for the protection of neurons against the risk of Alzheimer's and Parkinson's in women combining isoflavones and docosahexaenoic acid. | |
KR20190053309A (en) | Fuctional food improving skin condition comprising rice bran extract | |
JP2024020094A (en) | Use of low-dose glutathione as a skin brightening agent | |
IT202100003899A1 (en) | Food supplement for the nutri-cosmetic treatment of alopecia and cardiovascular prevention | |
JP2022186085A (en) | Glutathione production enhancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Withdrawal due to no request for examination |